YANKCOM Partnership’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$192K Buy
365
+35
+11% +$19.6K 0.07% 150
2026
Q1
$185K Sell
330
-1
-0.3% -$641 0.08% 142
2025
Q4
$224K Buy
331
+66
+25% +$44.9K 0.1% 135
2025
Q3
$169K Buy
+265
New +$161K 0.08% 146

Other funds holding IDXX

YANKCOM Partnership's IDXX Position: Q2 2026 in Review

YANKCOM Partnership increased its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, buying an estimated $19.6K and bringing the position to 365 shares worth $192K. The position accounts for 0.07% of the portfolio, ranked #150.

YANKCOM Partnership first reported a position in IDXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $224K in Q4 2025. 689 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • YANKCOM Partnership held 365 shares of Idexx Laboratories worth $192K as of Q2 2026.
  • YANKCOM Partnership bought 35 Idexx Laboratories shares in Q2 2026, an estimated $19.6K.
  • Idexx Laboratories made up 0.07% of YANKCOM Partnership's portfolio in Q2 2026, its #150 holding.
  • YANKCOM Partnership first reported a position in Idexx Laboratories in Q3 2025 and has held it in 4 quarters since.
  • YANKCOM Partnership's Idexx Laboratories position peaked at $224K in Q4 2025.
  • 689 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.